What is AristaMD?
AristaMD is a pioneering health-tech enterprise dedicated to optimizing the patient referral process through its proprietary eConsult platform. By facilitating seamless electronic consultations between primary care physicians and board-certified specialists, the company addresses critical bottlenecks in the current healthcare delivery system. This telehealth solution is designed to integrate directly into existing clinical workflows, allowing providers to deliver high-quality, timely care while minimizing the necessity for in-person specialist visits.
The platform serves as a vital tool for payers and health systems aiming to transition toward value-based care. By providing access to a panel of expert specialists, AristaMD not only enhances patient satisfaction but also drives significant cost savings for healthcare stakeholders. Its market position is defined by its commitment to clinical excellence and its ability to scale virtual care solutions across diverse medical environments.
How much funding has AristaMD raised?
AristaMD has raised a total of $57.4M across 7 funding rounds:
Debt
$2.1M
Debt
$1.4M
Debt
$1.4M
Series A
$11M
Debt
$1M
Series B
$24M
Series C
$16.5M
Debt (2014): $2.1M with participation from Avalon Ventures, LLC
Debt (2015): $1.4M led by Undisclosed
Debt (2016): $1.4M supported by GoFormz Inc.
Series A (2016): $11M featuring Correlation Ventures and Avalon Ventures
Debt (2017): $1M, investors not publicly disclosed
Series B (2020): $24M with participation from MemorialCare, Ascension Ventures Ltd, Cigna Ventures, Stanford Health Care, CU Healthcare Innovation Fund, .406 Capital, and Avalon Ventures
Series C (2023): $16.5M, investors not publicly disclosed
Key Investors in AristaMD
Avalon Ventures
Avalon Ventures is a venture capital firm with over 30 years of experience focusing on seed and early-stage companies, particularly in the life sciences and information technology sectors.
Correlation Ventures
Correlation Ventures is focused on reinventing industries through innovative investment strategies, providing groundbreaking data science to help companies achieve lasting value.
MemorialCare
MemorialCare is a prominent hospital system operating primary hospitals and multiple outpatient facilities, bringing deep clinical expertise to their investment strategy.
What's next for AristaMD?
With the successful closure of its latest financing round, AristaMD is well-positioned to accelerate its product development and expand its footprint in the competitive telehealth landscape. The strategic allocation of these funds will likely focus on enhancing the platform's integration capabilities and broadening its network of specialists to meet the rising demand for virtual care. As the company scales, it will continue to refine its data-driven approach to specialty care, ensuring that its technology remains an essential component of modern, efficient healthcare delivery systems.
Looking ahead, AristaMD is poised to leverage its strong investor base to navigate the complexities of the evolving digital health market. By maintaining its focus on clinical outcomes and operational cost-effectiveness, the firm is set to play a pivotal role in the ongoing digital transformation of the medical industry, ultimately fostering a more accessible and equitable healthcare ecosystem.
